Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

868
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
868
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

787
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
787
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

22.8K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
22.8K
EDTA: Chemistry and Properties01:22

EDTA: Chemistry and Properties

2.7K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
2.7K
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

1.8K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
1.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

16.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diels-Alder Reactions in [Pd<sub>6</sub>L<sub>4</sub>]<sup>12+</sup> Metallocages: The Key Roles of Preorganization and Confinement.

Inorganic chemistry·2026
Same author

Super-Resolution Ultrasound Based Cell Tracking With Polymeric Nanobubbles.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics.

Chemical Society reviews·2026
Same author

Bimetallic Silver-Gold Nanoplates for Photothermal Antimicrobial Therapy: Integrating High Efficiency with Stable and Multifunctional Design.

ACS applied nano materials·2026
Same author

Impact of <i>N-</i>Terminal Histidine Methylation on Histidine-Brace Copper(II) Peptide Models of LPMOs.

Inorganic chemistry·2026
Same author

The evolutionary history of chelicerate metallothioneins reveals de novo emergence and metal-binding specialization across the subphylum.

Scientific reports·2026

Related Experiment Video

Updated: Nov 17, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.3K

Copper(II) N,N,O-Chelating Complexes as Potential Anticancer Agents.

Quim Peña1,2, Giuseppe Sciortino1,3, Jean-Didier Maréchal1

  • 1Departament de Química, Facultat de Ciències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain.

Inorganic Chemistry
|February 17, 2021
PubMed
Summary

Three new copper(II) complexes show promise as cancer cell killers. They generate reactive oxygen species (ROS) selectively in cancer cells, offering a potential new strategy for cancer treatment.

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.2K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.5K

Related Experiment Videos

Last Updated: Nov 17, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.3K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.2K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.5K

Area of Science:

  • Coordination Chemistry
  • Materials Science
  • Biomedical Applications

Background:

  • Metal complexes are explored for cancer therapy.
  • Reactive oxygen species (ROS) generation is a key mechanism for cancer cell death.
  • Copper complexes offer redox activity within biological windows.

Purpose of the Study:

  • Synthesize and characterize novel dinuclear Cu(II) complexes.
  • Investigate the structural behavior in solid-state and solution.
  • Evaluate the potential of these complexes as ROS generators and their selective cytotoxicity against cancer cells.

Main Methods:

  • Synthesis and characterization of three dinuclear Cu(II) complexes.
  • X-ray crystallography and computational studies for structural analysis.
  • Mass spectrometry and electron paramagnetic resonance (EPR) for solution behavior.
  • In vitro cytotoxicity assays on HeLa, MCF7, and normal fibroblast cell lines.

Main Results:

  • Novel dinuclear Cu(II) complexes with varying aromatic substituents were synthesized.
  • Complexes exhibit dimeric structure in solid-state and coexist with monomeric form in solution.
  • High potential as ROS generators with Cu(II)/Cu(I) redox cycling capability.
  • Promising selective cytotoxicity against HeLa and MCF7 cancer cell lines (IC50 ~25 μM in HeLa).

Conclusions:

  • The N,N,O-chelating salphen-like ligand scaffold is effective for designing Cu(II) complexes.
  • These complexes demonstrate potential for selective cancer cell death via ROS generation.
  • The developed Cu(II) complexes represent a promising platform for future anticancer drug development.